Premature ovarian insufficiency: the context of long-term effects
A Podfigurna-Stopa, A Czyzyk, M Grymowicz… - Journal of …, 2016 - Springer
Purpose Premature ovarian insufficiency (POI) is defined as the cessation of the ovarian
function before the age of 40 years. POI aetiology may be related to iatrogenic or …
function before the age of 40 years. POI aetiology may be related to iatrogenic or …
EMAS position statement: predictors of premature and early natural menopause
Introduction While the associations of genetic, reproductive and environmental factors with
the timing of natural menopause have been extensively investigated, few epidemiological …
the timing of natural menopause have been extensively investigated, few epidemiological …
EMAS position statement: the ten point guide to the integral management of menopausal health
M Neves-e-Castro, M Birkhauser, G Samsioe… - Maturitas, 2015 - Elsevier
With increased longevity and more women becoming centenarians, management of the
menopause and postreproductive health is of growing importance as it has the potential to …
menopause and postreproductive health is of growing importance as it has the potential to …
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical …
N Mendoza, I Ramírez, E De la Viuda, P Coronado… - Maturitas, 2022 - Elsevier
This project aims to develop eligibility criteria for menopausal hormone therapy (MHT). The
tool should be similar to those already established for contraception A consortium of …
tool should be similar to those already established for contraception A consortium of …
Pyrethroid pesticide exposure and risk of primary ovarian insufficiency in Chinese women
C Li, M Cao, L Ma, X Ye, Y Song, W Pan… - … science & technology, 2018 - ACS Publications
Pyrethroids are a class of widely used insecticides. Female animal studies suggested that
pyrethroid exposure impaired ovarian function, which resulted in similar symptoms of …
pyrethroid exposure impaired ovarian function, which resulted in similar symptoms of …
Menopause guideline appraisal and algorithm development for premature ovarian insufficiency
Abstract Objectives Clinical practice guidelines (CPGs) are systematically developed
statements that guide clinicians to provide appropriate healthcare. The aims of this study …
statements that guide clinicians to provide appropriate healthcare. The aims of this study …
[HTML][HTML] Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study
PURPOSE: The aim of this study was to evaluate serum levels of inducible nitric oxide
synthase (INOS), myeloperoxidase (MPO), total antioxidant status (TAS), and total oxidative …
synthase (INOS), myeloperoxidase (MPO), total antioxidant status (TAS), and total oxidative …
Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study
L Baquedano, A Espiau, M Fasero, S Ortega… - BMC Women's …, 2020 - Springer
Objective To study what women think about menopause treatments and assess their
knowledge about them. To analyze adherence to treatment during COVID-19 confinement …
knowledge about them. To analyze adherence to treatment during COVID-19 confinement …
Management of bone health in women with premature ovarian insufficiency: systematic appraisal of clinical practice guidelines and algorithm development
V Kiriakova, SD Cooray, L Yeganeh, G Somarajah… - Maturitas, 2019 - Elsevier
Background Osteoporosis is a key concern of women with premature ovarian insufficiency
(POI) but there are gaps in clinicians' knowledge of bone health. Objectives 1) To …
(POI) but there are gaps in clinicians' knowledge of bone health. Objectives 1) To …
Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI)
K Szlendak-Sauer, D Jakubik, M Kunicki… - European Journal of …, 2016 - Elsevier
Objectives Autoimmune polyglandular syndrome type 3–(APS-3), is defined as the
coexistence of autoimmune thyroiditis with other non-ovarian autoimmune diseases without …
coexistence of autoimmune thyroiditis with other non-ovarian autoimmune diseases without …